← Open Payments lookup

JESSICA MULCAHY: Open Payments

NPI 1053883645 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,055 in 59 payments from 12 companies in 2025. Trend: 2023 $818 · 2024 $688 · 2025 $1,055

Food & beverage: $1,055
CompanyPaymentsAmount
Madrigal Pharmaceuticals16$266
ABBVIE INC.15$234
Takeda Pharmaceuticals U.S.A., Inc.7$188
GENZYME CORPORATION3$83
Phathom Pharmaceuticals, Inc.7$68
Janssen Biotech, Inc.3$59
Regeneron Healthcare Solutions, Inc.2$46
Ardelyx, Inc.2$39
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$22
IRONWOOD PHARMACEUTICALS, INC1$18

Products named: REZDIFFRA, EOHILIA, RINVOQ, DUPIXENT, VOQUEZNA, TREMFYA, LINZESS, IBSRELA.

Industry payments across NE — which companies pay providers there.